大麻二醇在抑郁症治疗中的治疗潜力
Matti Bock Guldager1, Adriano Maia Chaves Filho2, Caroline Biojone1
1Department of Biomedicine, Health Faculty, Aarhus University, Aarhus, Denmark; Translational Neuropsychiatry Unit (TNU), Department of Clinical Medicine, Health Faculty, Aarhus University, Aarhus, Denmark.
International review of neurobiology
|July 19, 2024
概括
大型抑郁症 (MDD) 的治疗方法有限. 大麻素 (CBD) 通过影响大脑信号,神经炎症和神经可塑性来显示潜力,为MDD治疗提供了一条新的途径.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 大型抑郁症 (MDD) 影响全球许多人,目前基于单胺胺的治疗方法的疗效有限.
- 现有的MDD治疗方法往往导致患者的反应延迟,残留症状或无反应.
- 由于当前治疗方法的局限性,抑郁症的单氨基基假设被认为是减少主义的.
研究的目的:
- 探索大麻 (CBD) 作为一种新型治疗MDD的潜力.
- 审查研究CBD对抑郁症的影响的临床前和临床研究.
- 阐明CBD在MDD中的治疗作用背后的分子机制.
主要方法:
- 对CBD对动物抑郁症模型的影响进行临床前研究的综述.
- 对检查CBD用于MDD治疗的人类临床研究的分析.
- 调查CBD的分子标,包括单胺和内分泌大麻素系统,神经炎症和神经可塑性.
主要成果:
- 临床前研究表明,CBD表现出类似抗抑郁药的效果.
- 新兴的临床数据表明,CBD在治疗MDD症状方面具有前景.
- CBD的机制可能涉及调节神经递质系统,减少神经炎症和促进神经可塑性.
结论:
- CBD为严重抑郁症提供了一个有前途的治疗候选者.
- 需要进一步的研究来充分了解CBD在MDD的疗效和安全性.
- CBD的多方面的机制为传统抗抑郁药疗法提供了潜在的替代方案.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
209
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
209
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
174
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
174
Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
G-protein Coupled Receptors
117.8K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
117.8K
Depression: Overview
231
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
231


